Particle engineering: Fundamentals of particle formation and crystal growth

MRS Bulletin

Volumn 31, Issue 11, 2006, Pages 881-886

  Lee, Alfred Y ^a   Myerson, Allan S ^a  

^a NONE

Author keywords

Crystal growth; Morphology; Nucleation; Particle

Indexed keywords

CRYSTAL GROWTH; CRYSTALLINE MATERIALS; DRUG DOSAGE; MODIFICATION; MORPHOLOGY; NUCLEATION; PARTICLES (PARTICULATE MATTER);

CRYSTALLINE PRODUCTS; PACKING ARRANGEMENT; PARTICLE ENGINEERING; PARTICLE PROPERTIES;

DRUG PRODUCTS;

EID: 37849185626     PISSN: 08837694     EISSN: None     Source Type: Journal    
DOI: 10.1557/mrs2006.207     Document Type: Article

References (86)

1. E.L. Paul, H.H. Tung, and M. Midler, Powd. Technol. 150 (2005) p. 133.
2. B.Y Shekunov and P. York, J. Cryst. Growth 211 (2000) p. 122.
3. G. Desiraju, Crystal Engineering: The Design of Organic Solids (Elsevier, Amsterdam, 1989).
4. P. Erk, H. Hengelsberg, M.F. Haddow, and R. Van Gelder, Cryst. Eng. Comm. 6 (2004) p. 474.
5. M. Volmer, Kinetik der Phasenbildung (Steinkopff, Germany, 1939).
6. D.W. Oxtoby, Acc. Chem. Res. 31 (1998) p. 91.
7. P.G. Vekilov, Cryst. Growth Des. 4 (2004) p. 671.
8. F. Schuth, Curr. Opin. Solid State Mater, Sci. 5 (2001) p. 389.
9. D.W. Oxtoby, Philos. Trans. R. Soc. London, Ser. A. 361 (2003) p. 419.
10. P.R. ten Wolde and D. Frenkel, Science 277 (1997) p. 1975.
11. J.D. Shore, D. Perchak, and Y. Shnidman, J. Chem. Phys. 113 (2000) p. 6276.
12. O. Galkin and P.G. Vekilov, J. Am. Chem. Soc. 122 (2000) p. 156.
13. S. Chattopadhyay, D. Erdemir, J.M.B. Evans, J. Ilavsky, H. Amenitsch, C.U. Segre, and A.S. Myerson, Cryst. Growth. Des. 5 (2005) p. 523.
14. M. Kimura, Cryst. Growth Des. 6 (2006) p. 854.
15. B.A. Garetz, J. Matic, and A.S. Myerson, Phys. Rev. Lett. 89 175501 (2002).
16. R.J. Davey, K. Allen, N. Blagden, W.I. Cross, H.F. Lieberman, M.J. Quayle, S. Righini, L. Seton, and G.J.T. Tiddy, Cryst. Eng. Comm. 4 (2002) p. 257.
17. R. Hilfiker, Ed., Polymorphism in the Pharmaceutical Industry (John Wiley & Sons, Chichester, 2006);
18. G. Winter, in Reactivity of Molecular Solids, edited by E.V. Boldyreva and V.V. Boldyrev (John Wiley & Sons, Chichester, 1999) p. 241.
19. J. Bernstein, Polymorphism in Molecular Crystals (Oxford University Press, New York, 2002).
20. J.O. Henck, U.J. Griesser, and A. Burger, Pharm. Ind. 59 (1997) p. 165.
21. M.R. Caira, in Topics in Current Chemistry, Vol. 198, edited by E. Weber (Springer, New York, 1998) p. 163.
22. S. Briancon and H. Fessi, STP Pharma. Prat. 13 (2003) p. 215;
23. E. Doelker, STP Pharma. Prat. 9 (1999) p. 399.
24. C. Sun and D.J.W. Grant, Pharm. Res. 18 (2001) p. 274;
25. C. Sun and D.J.W. Grant, Pharm. Res. 21 (2004) p. 382.
26. X. Chen, K.R. Morris, U.J. Griesser, S.R. Byrn, and J.G. Stowell, J. Am. Chem. Soc. 124 (2002) p. 15012.
27. J.D. Dunitz and J. Bernstein, Acc. Chem. Res. 28 (1995) p. 193.
28. A. Gavezzotti and G. Filippini, J. Am. Chem. Soc. 117 (1995) p. 12299.
29. J. Bauer, S. Spanton, R. Henry, J. Quick, W. Dziki, W. Porter, and J. Morris, Pharm. Res. 18 (2001) p. 859.
30. J.K. Guillory, in Polymorphism in Pharmaceutical Solids, edited by H.G. Brittain (Marcel Dekker, New York, 1999) p. 183;
31. M. Maiwald, Am. Pharm. Rev. 9 (2006) p. 95.
32. M. Janik, Z. Malarski, J. Mrozinski, J. Wajcht, and Z. Zborucki, J. Crystallogr, Spectrosc. Res. 21 (1991) p. 519.
33. S.L. Morissette, O. Almarsson, M.L. Peterson, J.F. Remenar, M.J. Read, A.V. Lemmo, S. Ellis, M.J. Cima, and C.R. Gardner, Adv. Drug Delivery Rev. 56 (2004) p. 275.
34. H. Furedi-Milhofer, N. Garti, and A. Kamyshny, J. Cryst. Growth 198-199 (1999) p. 1365.
35. J.M. Ha, J.H. Wolf, M.A. Hillmyer, and M.D. Ward, J. Am. Chem. Soc. 126 (2004) p. 3382.
36. A.Y. Lee, I.S. Lee, S.S. Dette, J. Boerner, and A.S. Myerson, J. Am. Chem. Soc. 127 (2005) p. 14982.
37. C.P. Price, A.L. Grzesiak, and A.J. Matzger, J. Am. Chem. Soc. 127 (2005) p. 5512.
38. R. Hiremath, J.A. Basile, S.W. Varney, and J.A. Swift, J. Am. Chem. Soc. 127 (2005) p. 18321.
39. S. Chen, H. Xi, and L. Yu, J. Am. Chem. Soc. 127 (2005) p. 17439.
40. M.C. Meyer, A.B. Straughn, E.J. Jaryi, G.C. Wood, F.R. Pelsor, and V.P. Shah, Pharm. Res. 9 (1992) p. 1612.
41. S.L. Price, Adv. Drug. Delivery Rev. 56 (2004) p. 301.
42. R. Docherty and P. Meenan, in Molecular Modeling Applications in Crystallization, edited by A.S. Myerson (Cambridge University Press, Cambridge, 1999) p. 106.
43. P. Verwer and F.J.J. Leusen, in Reviews in Computational Chemistry, Vol. 12, edited by K.B. Lipkowitz and D.B. Boyd (John Wiley & Sons, New York, 1998) p. 327;
44. R.J. Gdanitz, Curr. Opin. Solid State Mater. Sci. 3 (1998) p. 414.
45. J.P.M. Lommerse, W.D.S. Motherwell, H.L. Ammon, J.D. Dunitz, A. Gavezzotti, D.W.M. Hofmann, F.J.J. Leusen, W.T.M. Mooij, S.L. Price, B. Schweizer, MU. Schmidt, B.P. van Eijck, P. Verwer, and D.E. Williams, Acta Crystallogr., Sect. B: Struct. Sci. 56 (2000) p. 697;
46. W.D.S. Motherwell, H.L. Ammon, J.D. Dunitz, A. Dzyabchenko, P. Erk, A. Gavezzotti, D.W.M. Hofmann, F.J.J. Leusen, J.P.M. Lommerse, W.T.M. Mooij, P. Verwer, and D.E. Williams, Acta Crystallogr., Sect. B: Struct. Sci. 58 (2002) p. 647;
47. G.M. Day, W.D.S. Motherwell, H.L. Ammon, S.X.M. Boerrigter, R.G. Della Valle, E. Venuti, A. Dzvabchenko, J.D. Dunitz, B. Schweizer, B.P. van Eijck, P. Erk, J.C. Facelli, V.E. Bazterra, M.B. Ferraro, D.W.M. Hofmann, F.J.J. Leusen, C. Liang, C.C. Pantelides, P.G. Karamertzanis, S.L. Price, T.C. Lewis, H. Nowell, A. Torrisi, H.A. Scheraga, Y.A. Arnautova, M.U. Schmidt, and P. Verwer, Acta Crystallogr., Sect. B: Struct. Sci. 61 (2005) p. 511.
48. S.L. Price, in Reviews in Computational Chemistry, Vol. 14, edited by K.B. Lipkowitz and D.B. Boyd (John Wiley & Sons, New York, 2000) p. 225.
49. T. Beyer, T. Lewis, and S.L. Price, Cryst. Eng. Comm. 44 (2001) p. 1.
50. J.D. Dunitz, Chem. Commun. (2003) p. 545.
51. J.K. Haleblian, J. Pharm. Sci. 64 (1975) p. 1269.
52. E.M. Walker, K.J. Roberts, and S.J. Maginn, Langmuir 14 (1998) p. 5620.
53. I. Weissbuch, R. Popovitz-Biro, M. Lahav, and L. Leiserowitz, Acta Crystallogr., Sect. B: Struct. Sci. 51 (1995) p. 115.
54. L. Addadi, S. Weinstein, E. Gati, I. Weissbuch, and M. Lahav, J. Am. Chem. Soc. 104 (1982) p. 4610.
55. L. Addadi, Z. Berkovitch-Yellin, I. Weissbuch, M. Lahav, and L. Leiserowitz, Mol. Cryst. Liq. Cryst. 96 (1982) p. 1.
56. R.J. Davey, N. Blagden, G.D. Potts, and R. Docherty, J. Am. Chem. Soc. 119 (1997) p. 1767;
57. T. Mukuta, A.Y. Lee, T. Kawakami, and A.S Myerson, Cryst. Growth Des. 5 (2005) p. 1429.
58. L. Addadi, Z. Berkovitch-Yellin, N. Domb, E. Gati, M. Lahav, and L. Leiserowitz, Nature 296 (1982) p. 21.
59. B. Kahr and R.W. Gurney, Chem. Rev. 101 (2001) p. 893.
60. H. Colfen and L. Qi, Chem. Eur. J. 7 (2001) p. 106.
61. A. Kuldipkumar, Y.T.F. Tan, M. Goldstein, Y. Nagasaki, G.G.Z. Zhang, and G.S. Kwon, Cryst. Growth Des. 5 (2005) p. 1781.
62. N. Rasenack and B.W. Muller, Int. J. Pharm. 244 (2002) p. 45.
63. G.M. Khan and Z. Jiabi, Drug Dev. Ind. Pharm. 24 (1998) p. 463.
64. W.M.L. Wood, Powd. Technol. 121 (2001) p. 53.
65. V. Chikhalia, R.T. Forbes, R.A. Storey, and M. Ticehurst, Eur. J. Pharm. Sci. 27 (2006) p. 19.
66. X.M. Zeng, G.P. Martin, C. Marriott, and J. Pritchard, Int. J. Pharm. 200 (2000) p. 93.
67. M. Brunsteiner and S.L Price, Cryst. Growth Des. 1 (2001) p. 447.
68. X.Y. Liu, E.S. Boek, W.J. Briels, and P. Bennema, Nature 374 (1995) p. 342;
69. D. Winn and M.F. Doherty, AIChe J. 44 (1998) p. 2501.
70. S.X.M. Boerrigter, H.M. Cuppen, R.I. Ristic, J.N. Sherwood, P. Bennema, and H. Meekes, Cryst. Growth. Des. 2 (2002) p. 357.
71. Z. Berkovitch-Yellin, J. Am. Chem. Soc. 107 (1985) p. 8239.
72. P. Mougin, G. Clydesdale, R.B. Hammond, and K.J. Roberts, J. Phys. Chem. B 107 (2003) p. 13262.
73. A.J. Hickey, ed., Pharmaceutical Inhalation Aerosol Technology (Marcel Dekker, New York, 1992).
74. C.A. Lipinski, Am. Pharm. Rer. 5 (2002) p. 82.
75. D. Horn and J. Rieger, Angrw. Chem. Int. F.d. 40 (2001) p. 4330.
76. G.G. Liversidge and K.C. Cundy, Int. J. Pharm. 125 (1995) p. 91.
77. T.P. Shakhtshneider and V.V. Boldyrev, in Reactivity of Molecular Solids, edited by E.V. Boldyreva and V.V. Boldyrev (John Wiley & Sons, Chichester, 1999) p. 271.
78. J.E. Kipp, Int. J. Pharm. 284 (2004) p. 109;
79. B.E. Rabinow, Nat. Rev. Drug Disc. 3 (2004) p. 785.
80. M. Midler Jr., E.P. Paul, E.F. Whittington, M. Futran, P.D. Liu, J. Hsu, and S.H. Pan, "Crystallization method to improve crystal structure and size," U.S. Patent No. 5,314,506 (May 24, 1994).
81. P. York, U.B. Kompella, and B.Y. Shekunov, eds., Supercritical Fluid Technology for Drug Product Development (Marcel Dekker, New York, 2004).
82. M. Sacchetti and M.M. Van Dort, in Inhalation Aerosols, edited by A.J. Hickey (Marcel Dekker, New York, 1996) p. 337.
83. J. Yano, H. Furedi-Milhofer, E. Wachtel, and N. Garti, Langmuir 16 (2000) p. 10005.
84. A.I. Kitaigorodsky, Molecular Crystals and Molecules (Academic Press, New York, 1973).
85. J.W. Mullin, Crystallization (Butterworth-Heinemann, Boston, 2001).
86. A.Y. Lee, I.S. Lee, and A.S. Myerson, Chem. Eng. Technol. 29 (2006) p. 281.